Accessibility Menu
Demant A/s logo

Demant A/s(OTC) WILYY

Market Cap$9.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+150%
5 Year-21%
1 Year+20%
1 Month+10%
$22.70
+0.13%
+0.03Today
Demant A/s last closing stock price
MetricPriceDate
Last closeUSD 22.702026-09-02
Demant A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.24%USD 21.992026-08-26
1 month+9.87%USD 20.662026-08-03
3 month+17.19%USD 19.372026-06-04
Year to date+38.5%USD 16.392025-12-31
1 year+19.52%USD 18.992025-09-02
3 year+10.73%USD 20.502023-09-01
5 year-20.99%USD 28.732021-09-03
Since inception+149.59%USD 9.102011-07-01

Demant A/s Financials at a Glance

Market Cap

$9.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

DKK 47.56B

Net Income (TTM)

DKK 3.94B

EPS (TTM)

$0.60

P/E Ratio

37.71

Dividend

$0.00

Beta (Volatility)

0.32 (Low)

Price

$22.70

Volume

1

Open

$22.70

Previous Close

$22.70

Daily Range

$22.70 - $22.70

52-Week Range

$13.45 - $23.00

Estimated Earnings Date

May 27, 2026

WILYY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Demant A/s

Demant A/S is a leading hearing healthcare company operating globally, with a strong presence in Europe, North America, and Asia. The company specializes in the development, manufacture, and wholesale of hearing aids, as well as providing hearing care clinics and assessment solutions for audiologists and ENT doctors.

Products and Services
  • Hearing aids designed for various levels of hearing loss
  • Hearing care clinics offering personalized services
  • Assessment solutions for audiologists and balance clinics
Growth Outlook
  • Revenue increased to 13.25 billion DKK in Q2 2026, reflecting strong demand
  • Operating income margin improved to 17.1% in Q2 2026, indicating operational efficiency
  • Continued investment in R&D, with 758 million DKK allocated in Q2 2026
Financial Highlights
  • Net income reached 1.21 billion DKK in Q2 2026, showcasing profitability
  • Gross profit margin improved to 77.2% in Q2 2026, highlighting cost management
  • Operating cash flow of 1.64 billion DKK in Q2 2026 supports financial stability
Demant A/S has established itself as a key player in the hearing healthcare sector, driven by innovation and a commitment to quality. The company's diverse product offerings and strategic investments in research and development position it well for future growth. Recent financial performance indicates a robust operational framework, with increasing revenues and improving profit margins. The focus on enhancing customer experience through clinics and advanced assessment solutions further strengthens its market position. As the global demand for hearing solutions continues to rise, Demant A/S is poised to capitalize on these opportunities, making it an intriguing option for potential investors.
AI Generated • Aug 25, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

26,704

CEO

Søren Nielsen

Website

www.demant.com

Headquarters

Smørum, ZE 2765, DK

WILYY Financials

Key Financial Metrics (TTM)

Gross Margin

70.96%

Operating Margin

17.88%

Net Income Margin

6.51%

Return on Equity

15.31%

Return on Capital

12.68%

Return on Assets

4.03%

Earnings Yield

2.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

417.71M

Volume

1

Avg. Volume

117.078

Financials (TTM)

Gross Profit

DKK 36.21B

Operating Income

DKK 8.38B

EBITDA

DKK 11.98B

Operating Cash Flow

DKK 8.48B

Capital Expenditure

-DKK 1.43B

Free Cash Flow

DKK 7.05B

Cash & ST Invst.

DKK 1.50B

Total Debt

DKK 20.28B

Demant A/s Performance Analysis

Demant A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31DKK 2,755,207,491-3.0%
20232023-12-31DKK 3,149,613,38114.3%
20242024-12-31DKK 3,251,987,0343.3%
20252025-12-31DKK 3,489,941,1867.3%
Demant A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-312.2%
Q22025-06-30-0.7%
Q42025-12-314.2%
Q22026-06-3013.0%
Demant A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31DKK 0.65-23.5%
20232023-12-31DKK 0.58-10.3%
20242024-12-31DKK 0.8138.0%
20252025-12-31DKK 0.55-31.3%
Demant A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-23.6%
Q22025-06-3013.1%
Q42025-12-31-68.4%
Q22026-06-30240.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

DKK 13.25B

+19.5%

Gross Profit

DKK 10.23B

+20.2%

Gross Margin

77.23%

N/A

Market Cap

$9.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$355.08K

N/A

Employees

26,704

N/A

Net Income

DKK 1.21B

+1.0%

EBITDA

DKK 3.17B

+34.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

DKK 1.50B

+42.8%

Total Debt

DKK 20.28B

+28.2%

Accounts Receivable

DKK 5.26B

+41.8%

Inventory

DKK 2.81B

+5.0%

Long Term Debt

DKK 13.13B

-0.5%

Short Term Debt

DKK 7.16B

+171.8%

Return on Assets

4.03%

N/A

Return on Invested Capital

16.05%

N/A

Free Cash Flow

DKK 1.37B

+50.6%

Operating Cash Flow

DKK 1.64B

+36.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDUUFBangkok Dusit Medical Services Public Company Limited
$0.64+0.00%
ESALFEisai Co., Ltd.
$31.00+0.00%
ESAIYEisai Co., Ltd.
$7.67+3.16%
SSMXYSysmex Corporation
$12.46+3.84%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About WILYY

What is the current price of Demant A/s?

Demant A/s is trading at $22.70 per share.

What is the 52-week range for Demant A/s?

Over the past 52 weeks, Demant A/s has traded between $13.45 and $23.00.

How much debt does Demant A/s have?

As of the most recent reporting period, Demant A/s reported total debt of DKK 3.30B.

How much cash does Demant A/s have on hand?

Demant A/s reported DKK 209.13M in cash and cash equivalents in its most recent financial results.

What is Demant A/s’s dividend yield?

Demant A/s does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services